Provided by Healio
May 13, 2014
CHICAGO — Bruce R. Bacon, MD, James F. King, MD, Endowed Chair in Gastroenterology, St. Louis University School of Medicine, discusses the advances in hepatitis C demonstrated by studies presented at Digestive Disease Week, and the results from the SAPPHIRE-II and ION studies that showed high cure rates across many patient groups.
“One of the most exciting concepts that’s going around at this meeting and a few weeks ago at the EASL meeting is the tremendous advances in treatment of viral hepatitis with the new interferon-free regimens,” Bacon told Healio.com. “These medicines were very well tolerated without any significant side effects, short duration of treatment and high efficacy.”
No comments:
Post a Comment